Neeraja Pabbaraju

Dr. Neeraja Pabbaraju


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
KKK. Kranthi Kumar
K. Kranthi Kumar
BDB. Uma Devi
B. Uma Devi
NPNeeraja Pabbaraju
Neeraja Pabbaraju

30 April 2022 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
KKKranthi Kumar Konidala
Kranthi Kumar Konidala
UBUmadevi Bommu
Umadevi Bommu
NPNeeraja Pabbaraju
Neeraja Pabbaraju

24 April 2018 in SAR and QSAR in Environmental Research
Verified
Journal Article
Closed access
KKK. Kranthi Kumar
K. Kranthi Kumar
BDB. Uma Devi
B. Uma Devi
NPNeeraja Pabbaraju
Neeraja Pabbaraju
In this study, cholesterol biotransformation gene-set of human steroidogenic acute regulatory protein-related lipid transfer (START) domains were evaluated from high-throughput gene screening approaches. It was shown that STARD1, STARD3 and STARD4 proteins are better effective transporters of cholesterol than STARD5 and STARD6 domains. Docking studies show a strong agreement with gene ontology enrichment data. According to both complementary strategies, it was found that only STARD1, STARD3 and STARD4 are potentially involved in cholesterol biotransformation in mitochondria through Ω1-loop of C-terminal α4-helical domain. Ensemble docking assessment for a set of selected chemicals of protein–chemical networks has shown possible binding probabilities with START domains. Among those, reproductive toxicity evoked drugs (mifepristone), insecticides (rotenone), tobacco pulmonary carcinogens (benzo(a)pyrene) and endocrine disruptor chemicals (EDCs) including perfluorooctanesulfonic acid (PFOS) and aflatoxin B1 (AFB1) potentially bound with novel hotspot residues of the α4-helical domain. Compound representation space and clustering approaches reveal that the START proteins show more sensitivity with these lead scaffolds, so they could provide probable barrier assets in cholesterol and steroidogenic acute regulatory (StAR) binding and leads adverse consequences in steroidogenesis. These findings indicate potential START domains and their binding levels with toxic chemicals; sorted viewpoints could be useful as a promising way to identify chemicals with related steroidogenisis impacts on human health.

23 August 2018 in 3 Biotech
Verified
Journal Article
Closed access
PDF file
KKKranthi Kumar Konidala
Kranthi Kumar Konidala
UBUma Devi Bommu
Uma Devi Bommu
SYSuneetha Yeguvapalli
Suneetha Yeguvapalli
NPNeeraja Pabbaraju
Neeraja Pabbaraju

1 March 2019 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
KKK. Kranthi Kumar
K. Kranthi Kumar
PYP. Yugandhar
P. Yugandhar
BDB. Uma Devi
B. Uma Devi
TKT. Siva Kumar
T. Siva Kumar
NSN. Savithramma
N. Savithramma
NPNeeraja Pabbaraju
Neeraja Pabbaraju

4 July 2018 in Journal of Receptors and Signal Transduction
Verified
Journal Article
Closed access
KKKranthi Kumar Konidala
Kranthi Kumar Konidala
UBUma Devi Bommu
Uma Devi Bommu
NPNeeraja Pabbaraju
Neeraja Pabbaraju
In this study, binding efficiency of new pyrrolopyrimidine structural analogs against human vascular endothelial growth factor receptor-2 (VEGFR-2) were elucidated using integrated in silico methods. Optimized high-resolution model of VEGFR-2 was generated and adopted for structure-based virtual screening approaches. Pyrrolopyrimidine inhibitor (CP15) associated compounds were screened from PubChem database and subjected to virtual screening and comparative docking methods against the receptor ligand-binding domain. Accordingly, high efficient compounds were clustered with similarity indices through PubChem structure cluster module using single-linkage algorithm. Moreover, pharmacokinetics including drug metabolism activities of high-binding leads under investigation was portrayed using ADMET and similarity ensemble analysis. Optimal energy orientations of the selected protein model have been shown to be reliable, and highly recommended for screening and docking studies. Docking and clustering strategies were shown that nineteen candidates as most effective binders for VEGFR-2 than CP15, and are grouped as three classes. Lys868, Glu885, Cys919, His1026, Arg1027, Asp1046, and Gly1048 residues were predicted as novel hotspot residues, and participate in H-bonds, π-cation, π-stacking, halogen bonds, and salt-bridges formation with ligands. These additional bonds are contributing extent stability that holds the receptor structure at flexible state, this make difficult to any further conformational changes for evoking angiogenic signals. The ADMET and similarity ensemble analysis results were strongly indicated that thirteen candidates as best ligands for angiogenesis targets. Altogether, these findings indicate potential angiogenic templates and their binding levels with VEGFR-2; sorted viewpoints could be useful as a promising way to describe potential angiogenesis inhibitors with related molecular targets.